• SENSEX 72,480.29
    -48.78 (--0.07%)
  • BANKNIFTY 54,633.05
    373.10 (+0.69%)
  • Avalon Tech
    2,171.00 778.15(%)
  • Bharti Airtel
    1,753.30 1,745.00(%)
  • NSE
    1,761.00 1,761.00(%)
  • Molbio Diagnosti
    1,368.00 1,686.50(%)
  • Apollo Hospitals
    8,063.00 6,680.00(%)
  • Innova Captab
    1,080.00 608.25(%)
  • Hero Motors
    152.58 156.03(%)
  • Meesho
    230.55 254.65(%)
  • Azad Engineering
    3,126.00 3,126.00(%)
  • Shadowfax Technologies
    278.10 98.60(%)
  • Cupid
    312.10 312.10(%)
  • L&T Finance Ltd
    264.75 234.90(%)
  • Lenskart Solut.
    698.00 725.00(%)
  • Reliance Industries
    1,196.30 1,611.20(%)
  • SS Retail
    761.45 888.00(%)
  • Sun TV Network
    664.60 664.60(%)
  • Solar Industries
    19,820.00 22,630.05(%)
  • PB Fintech.
    1,040.00 1,040.00(%)
  • National High
    168.00 142.00(%)
  • HDFC Bank
    709.70 682.00(%)
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison
Overview
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison

Oxygenta Pharmaceutical Ltd Pharmaceuticals - Indian - Bulk Drugs

  • Indian Private
  • BSE Code : 19443.0
  • ISIN : INE102E01018
48.22 0 (0.71%)
  • As on 30 Sep 2026 (EOD)

  • Today’s Low

    47.50

  • Today’s High

    49.14

  • Open

    47.50

  • Perv Close

    47.88

  • 52W Low

    43.00

  • 52W High

    71.75

Key Indicators

  • P/E(TTM)

    0.00

  • Mar.Cap (₹Cr.)

    178.33

  • Div & Yield %

    0.00

  • Book Value(₹)

    -11.54

  • Debt-Equity Ratio

    0.71

  • AGM Date

    30-Sep-2026

  • EPS

    0.00

  • P/E Ratio

    0.00

Financials Ratios

  • Debt-Equity Ratio

    -

  • Mar.Cap (₹Cr.)

    178.33

  • RONW (%)

    -

  • ROCE (%)

    -

Score Board

  • Equity (₹ in Cr.)

    36.98

  • BV (₹)

    -11.50

  • Sales( ₹ in Cr.)

    112.98

  • NP (in Cr.)

    -17.57

  • NP Var(%)

    -70.0

  • Div%

    0.0

  • CPS (₹)

    -4.10

  • EPS (₹)

    -4.80

  • Traded Value (₹ in Lakhs)

    178.33

  • 52 Week High

    71.75

  • 52 Week Low

    43.00

  • Price BSE

    48.0

  • Price NSE

    0.00

  • Market Capital( in Cr.)

    178.33

  • P/C Ratio

    -11.60

  • P/E Ratio

    -10.10

  • Price Vs.BV

    -4.80

View More
Invest Now!

Navigate The Market With Confidence

Your all-in-one destination for expert investment guidance and streamlined portfolio management solutions

Financials

All Values are in (₹Cr)
Particulars(INCOME) 2026 Mar 2025 Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar
INCOME :            
Sales Turnover 112.98 109.30 39.64 30.99 60.52 52.03
Excise Duty 0.00 0.00 0.00 0.00 0.00 0.00
Net Sales 112.98 109.30 39.64 30.99 60.52 52.03
Other Income 0.29 1.31 0.10 0.14 1.36 2.28
Stock Adjustments 8.20 3.76 1.53 4.63 -4.55 6.39
Total Income 121.47 114.37 41.27 35.76 57.33 60.70
EXPENDITURE :            
Raw Materials 110.34 100.23 35.06 28.64 42.67 43.02
Power and Fuel Cost 6.83 6.37 4.15 4.16 3.04 2.79
Employee Cost 7.61 6.76 5.96 5.74 0.58 4.08
Other Manufacturing Expenses 8.58 5.97 3.28 2.43 6.31 2.88
Selling and Administration Expenses 2.49 2.56 2.39 1.75 1.88 1.79
Miscellaneous Expenses 0.65 0.99 0.04 0.87 0.82 0.01
Employee Benefit Expenses 7.61 6.76 5.96 5.74 0.58 4.08
Less: Preoperative Expenditure 0.00 0.00 0.00 0.00 0.00 0.00
Total Expenses 136.51 122.87 50.89 43.59 55.31 54.57
Operating Profit -15.04 -8.51 -9.62 -7.83 2.02 6.12
Interest 4.82 2.23 1.59 1.49 0.92 1.78
Gross Profit -19.86 -10.74 -11.21 -9.32 1.10 4.34
Depreciation 2.32 3.61 2.66 2.05 1.59 1.20
Profit Before Tax -22.18 -14.35 -13.87 -11.37 -0.49 3.14
Current Tax 0.00 0.16 0.00 0.00 0.00 0.00
Fringe Benefit tax 0.00 0.00 0.00 0.00 0.00 0.00
Deferred Tax -4.61 -4.21 -10.39 0.20 0.12 0.21
Reported Net Profit -17.57 -10.30 -3.48 -11.57 -0.61 2.93
Extraordinary Items 0.00 0.05 0.04 -0.72 0.43 2.04
Adjusted Net Profit -17.57 -10.35 -3.52 -10.85 -1.04 0.89
Adjustment below Net Profit 0.00 0.00 0.00 0.00 0.00 0.00
P & L Balance brought forward -74.18 -63.88 -60.40 -48.83 -48.22 -51.15
Statutory Appropriations 0.00 0.00 0.00 0.00 0.00 0.00
Appropriations 0.00 0.00 0.00 0.00 0.00 0.00
P & L Balance carried down -91.75 -74.18 -63.88 -60.40 -48.83 -48.22
Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Preference Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Equity Dividend (%) 0.00 0.00 0.00 0.00 0.00 0.00
Dividend Per Share(Rs) 0.00 0.00 0.00 0.00 0.00 0.00
Earnings Per Share-Unit Curr -4.75 -2.78 -1.04 -8.15 -0.43 2.87
Earnings Per Share(Adj)-Unit Curr -4.75 -2.78 -1.04 -8.15 -0.43 -
Book Value -11.54 -6.93 -6.18 -32.53 -24.38 -37.27
Book Value(Adj)-Unit Curr -11.54 -6.93 -6.18 -32.53 -24.38 -

Shareholding Pattern

  • Promoter Group

    56.54%

  • Public Share Holding

    43.46%

Category of Shareholder No of Shares % Holdings Demat Shares Shareholders
A]. Promoter & Group
Foreign (Promoter & Group) - Bodies Corporate 0 0.00 0 0
Foreign (Promoter & Group)-Individuals (Non-Resident / Foreign) 0 0.00 0 0
Foreign Promoter(Institutional) 0 0.00 0 0
Promoter Others 0 0.00 0 0
Sub Total 0 0.00 0 0
[2] INDIAN
Bodies Corporate-Indian (Promoter & Group) 20,896,975 56.50 20,896,975 1
Government(Central / State)-Indian (Promoter & Group) 0 0.00 0 0
Directors & their Relatives-Indian (Promoter & Group) 0 0.00 0 0
Financial Institutions / Banks-Indian (Promoter & Group) 0 0.00 0 0
Individuals / Hindu Undivided Family-Indian (Promoter & Group) 12,895 0.03 12,895 1
Partnership Firms-Indian (Promoter & Group) 0 0.00 0 0
Persons Acting in Concert 0 0.00 0 0
Trusts 0 0.00 0 0
Others 0 0.00 0 0
Sub Total 20,909,870 56.54 20,909,870 2
Total ShareHolding for Promoter & Group
B]. Publice Share Holding
1] Institution
Government(Central / State) 0 0.00 0 0
Clearing Members 0 0.00 0 0
Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
Financial Institutions / Banks 0 0.00 0 0
Foreign Bank 0 0.00 0 0
Foreign Bodies Corporate/OCBs/FBC 0 0.00 0 0
Foreign Collaborators 0 0.00 0 0
Foreign Institutional Investors 0 0.00 0 0
Foreign Venture Capital Investors 0 0.00 0 0
Foreign Institution Other 0 0.00 0 0
Insurance Companies 0 0.00 0 0
Mutual Funds / UTI 9,700 0.03 0 3
Individuals (Non-Resident / Foreign) 0 0.00 0 0
NSDL Intransit 0 0.00 0 0
Others 0 0.00 0 0
Trusts 0 0.00 0 0
Venture Capital Funds 0 0.00 0 0
Sub total 9,700 0.03 0 3
2] Non Institution
Bodies Corporate 156,938 0.42 139,238 87
Clearing Members 0 0.00 0 0
Directors of their Relatives 0 0.00 0 0
Employees 0 0.00 0 0
Escrow Account 0 0.00 0 0
Foreign Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
NRIs/Foreign Individuals/Foreign Nationals 1,652,642 4.47 1,650,642 22
Foreign Non Institution Other 0 0.00 0 0
Hindu Undivided Families 134,761 0.36 134,761 51
Indian Public 0 0.00 0 0
Individuals holding nominal share capital in excess of Rs. 1 lakh 11,142,775 30.13 11,142,775 52
Individuals holding nominal share capital up to Rs. 1 lakh 2,970,680 8.03 1,757,250 9,976
Market Maker 0 0.00 0 0
NSDL Transit 0 0.00 0 0
Shares in transit 0 0.00 0 0
Societies 0 0.00 0 0
Trust & Foundation 0 0.00 0 0
Others 0 0.00 0 0
Sub Total 16,063,930 43.44 14,830,800 10,191
Total Public Shareholding
C]. Shares held by Custodians and against which Depository Receipts have been issued
ADR 0 0.00 0 0
GDR 0 0.00 0 0
Other Custodians 0 0.00 0 0
Total Shares held by Custodians and against which Depository Receipts have been issued 0 0.00 0 0
Grand Total ( A + B + C ) 36,983,500 100.00 35,740,670 10,196

Company Background

Oxygenta Pharmaceutical LtdPharmaceuticals - Indian - Bulk Drugs

  • Oxygenta Pharmaceutical Ltd
  • BSE Code : 19443.0
  • ISIN : INE102E01018

  • Incorporation Year

    1990

  • Registered Office

    Survey No 252/1 Aroor Village
    Sadasivapet Mandal, Medak,
    Telangana-502291

  • Telephone

    91-08455-250080/250280

  • FAX

    91-08455-250090

  • Chairman

  • Managing Director

  • Company Secretary

    Kumkum Bajaj

  • Auditor

    A M Reddy & D R Reddy

  • Face Value

    10

  • Listing

    BSE

  • Registrar

    Venture Capital & Corp. Inv.
    12-10-167 ,
    ,Bharath Nagar
    Mumbai - Hyderbad - 500018

Oxygenta Pharmaceutical Ltd Peer Comparison

Profit & Loss
Financial Ratios
Balance Sheet
Select Company Name LTP (₹) Revenue Sales P/E Ratio ROCE %
Oxygenta Pharma 48.22 113.27 112.98 -13.14 0.00
Abbott India 27,149.40 7,217.19 6,929.05 35.73 43.78
Astrazeneca Phar 6,188.75 2,304.07 2,275.58 91.21 27.86
Glaxosmi. Pharma 2,767.60 3,932.76 3,790.20 44.21 58.17
Novartis India 1,923.85 393.10 354.33 48.58 15.94
Cipla 1,350.00 20,102.60 18,979.95 35.48 13.88
Bliss GVS Pharma 695.35 773.53 729.81 64.62 12.51
Fermenta Biotec. 549.65 474.15 450.25 25.66 18.77
Amrutanjan Healt 514.30 520.13 502.55 27.55 24.16
Guj. Themis Bio. 387.75 168.25 165.82 103.68 18.05
Ambalal Sarabhai 39.51 19.52 3.94 73.17 6.77